Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery
Enrolling by invitationNot applicableNCT06443164
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study is to examine a single-session, 2-hour group intervention provided to a population of transgender or gender-diverse patients with chronic pain prior to gender-affirming surgery, to determine if participants who receive the intervention have less pain-related distress compared to participants randomly assigned to the control group.
Study details
- Official title
- Efficacy of a Single-session Treatment for Reducing Chronic Pain Prior to Gender-affirming Surgery
- Conditions
- Pain Catastrophizing
- Pain, Chronic
- Gender Identity
- Interventions
- Sponsor
- Oregon Health and Science University
- Start date
- 2024-05-15
- Primary completion
- 2025-12-31
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. affiliated with the OHSU Transgender Health Program and have completed their initial consultation for gender-affirming surgery, 2. who have chronic pain (defined as \> 3 months of pain), 3. who rate their average level of pain intensity as at least a 4 or higher (on 0-10 pain scale) 4. who have fluency in English. Empowered Relief may only be delivered by a certified instructor, and for this research study the instructor is only able to offer the curriculum in English. Exclusion Criteria: 1. have had a pain-focused behavioral therapy in the past year, or 2. have severe depression and/or moderate or higher risk of suicidality based on the person's score on the PHQ-9 greater than 20.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06443164